Health AI Central
Peer-Reviewed Publication
Cancer Epidemiol Biomarkers Prev2026October 1, 2026Journal Article

Point-of-care models for genetic testing among patients at risk of hereditary cancer: A systematic review.

Brandie Heald1, Holly LaDuca2, Deborah Hartzfeld1, Gebra Cuyun Carter3, Karen L White1, Heather A Johnson1
1Exact Sciences (United States) Madison United States.
2Ambry Genetics (United States) United States.
3Exact Sciences (United States) United States.
PubMed DOI

Abstract

Broadening recommendations for hereditary cancer testing have increased demand for genetics services and prompted alternatives to referral-based pre-test genetic counseling. This systematic review summarized testing models used by non-genetics providers in point-of-care settings and associated clinical outcomes. PubMed and Embase were searched from January 2014 to March 2024. Outcomes included tes…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.